Insufficient scRNA-seq data for expression of SRXN1 at single-cell level.
Insufficient scRNA-seq data for expression of SRXN1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4101.38 | 1444 / 1445 | 83% | 4.74 | 152 / 183 |
ovary | 100% | 1924.47 | 180 / 180 | 70% | 1.50 | 301 / 430 |
stomach | 100% | 3114.44 | 359 / 359 | 59% | 1.73 | 168 / 286 |
intestine | 100% | 2065.60 | 965 / 966 | 33% | 0.93 | 176 / 527 |
lung | 99% | 2800.46 | 575 / 578 | 14% | 0.33 | 161 / 1155 |
bladder | 100% | 3353.33 | 21 / 21 | 12% | 0.27 | 59 / 504 |
uterus | 99% | 1977.00 | 169 / 170 | 1% | 0.03 | 5 / 459 |
kidney | 100% | 2558.12 | 89 / 89 | 0% | 0.00 | 2 / 901 |
adrenal gland | 100% | 7351.99 | 258 / 258 | 0% | 0 | 0 / 230 |
prostate | 100% | 2113.19 | 245 / 245 | 0% | 0 | 0 / 502 |
thymus | 100% | 3765.78 | 652 / 653 | 0% | 0 | 0 / 605 |
breast | 100% | 1646.21 | 458 / 459 | 0% | 0 | 0 / 1118 |
adipose | 100% | 2000.74 | 1199 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1910.33 | 1321 / 1335 | 0% | 0 | 0 / 0 |
spleen | 98% | 1821.61 | 237 / 241 | 0% | 0 | 0 / 0 |
heart | 98% | 2949.96 | 846 / 861 | 0% | 0 | 0 / 0 |
brain | 98% | 2236.41 | 2588 / 2642 | 0% | 0.00 | 1 / 705 |
peripheral blood | 97% | 3538.32 | 905 / 929 | 0% | 0 | 0 / 0 |
liver | 97% | 2602.01 | 219 / 226 | 0% | 0.01 | 2 / 406 |
skin | 97% | 2419.55 | 1759 / 1809 | 0% | 0 | 0 / 472 |
muscle | 97% | 3472.66 | 779 / 803 | 0% | 0 | 0 / 0 |
pancreas | 91% | 1100.98 | 298 / 328 | 0% | 0 | 0 / 178 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0006979 | Biological process | response to oxidative stress |
GO_0005737 | Cellular component | cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0016667 | Molecular function | oxidoreductase activity, acting on a sulfur group of donors |
GO_0032542 | Molecular function | sulfiredoxin activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | SRXN1 |
Protein name | HBV preS1-transactivated protein 5 (Sulfiredoxin 1 homolog (S. cerevisiae), isoform CRA_a) (cDNA FLJ25552 fis, clone JTH02127) Sulfiredoxin-1 (EC 1.8.98.2) |
Synonyms | SRX hCG_1641060 C20orf139 PS1TP5 SRX1 |
Description | FUNCTION: Contributes to oxidative stress resistance by reducing cysteine-sulfinic acid formed under exposure to oxidants in the peroxiredoxins PRDX1, PRDX2, PRDX3 and PRDX4 . Does not act on PRDX5 or PRDX6 . May catalyze the reduction in a multi-step process by acting both as a specific phosphotransferase and a thioltransferase . . |
Accessions | ENST00000381962.4 Q9BYN0 Q8N7H8 |